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ABSTRACT
Introduction. Human papillomavirus (HPV) vaccination rates in 
Kansas historically have been low among children and adolescents. 
How Kansas parents and guardians perceive the HPV vaccine may 
influence vaccination rates among Kansas youth. Social media mes-
sages also may influence perceptions, suggesting implications for 
current and future disease and cancer burden.
Methods.xEligible Kansas guardians of children aged 9 - 17 years 
completed an online survey. The survey assessed their perceptions 
about a) HPV and the HPV vaccine, b) HPV and HPV vaccine rep-
resentation on social media, and c) the effects that social media has 
on their perceptions about HPV and the HPV vaccine.
Results. Most Kansas guardians (n = 55, 57.9%) indicated seeing 
information about HPV and the HPV vaccine on social media. Kansas 
guardians who had reported seeing information on social media 
about the HPV vaccine were significantly more likely to perceive 
that the HPV vaccine could kill their child than those who had not 
seen information (t(79) = 0.019). Additionally, children of wealthier 
Kansan guardians were vaccinated more than children of less wealthy 
guardians.
Conclusion. Social media messages may be influencing Kansan 
guardians to think the HPV vaccine is lethal in their children. Future 
campaigns increasingly should be focused on HPV vaccine safety and 
effectiveness. Kans J Med 2020;13:9-18.
INTRODUCTION
The U.S. Centers for Disease Control and Prevention (CDC) 
estimated that approximately 79 million Americans have human 
papillomavirus (HPV), with an incidence of 14 million new cases 
annually.1 The CDC stated that HPV infection “is so common that 
most sexually-active men and women will get at least one type of HPV 
at some point in their lives”.1 While HPV infection does not cause 
complications in every case, it is linked to genital warts and several 
types of cancer, including cervical, vulvar, vaginal, penile, anal, and 
oropharyngeal.2
In 2013, Kansas tied for last among U.S. states for the lowest rate 
of HPV vaccination completion.3 By county, HPV vaccination com-
pletion rates among 11 - 18 year old adolescents ranged from 3% to 
48%.4,5 For females in that age range, the HPV vaccination rates by 
county ranged from 4% to 58%,5,6 and for males in the same age range, 
1% to 42%.5,7 
According to the National Immunization Survey-Teen (NIS-
Teen),8 Kansas females and males 13 - 17 years of age consistently 
ranked low among the 50 U.S. states for receiving at least one, two, 
and three doses of the HPV vaccine, and for being up-to-date with 
recommended vaccination series (Table 1 and Table 2).
Table 1. HPV vaccination coverage, U.S. and Kansas females and 
males (13 - 17 years of age).8
Doses U.S. Kansas Kansas Rank (50 U.S. States)
Females
≥ One dose 68.9% 55.2% 48th
≥ Two doses 57.7% 40.0% 49th
≥ Three doses 44.0% 36.1% 43rd
Up-to-date with recommended 
vaccination series 53.1% 38.5% 48th
Males
≥ One dose 62.6% 49.8% 46th
≥ Two doses 48.8% 34.7% 47th
≥ Three doses 34.8% 24.8% 44th
Up-to-date with recommended 
vaccination series 44.3% 30.4% 47th
Since 2006, HPV vaccines have been available in the U.S.9 Both 
females and males can begin receiving an HPV vaccine at age nine, 
with early vaccination recommended so that recipients develop 
immunity prior to potential exposure.10 As of 2016, a two-dose series 
was approved for children younger than 15 years. While the HPV 
vaccine can prevent HPV infection, genital warts, and associated 
cancers, it often is met with feelings of hesitance, fear, and aversion. 
Studies of online and social media communities resulted in a range 
of results, from mostly positive attitudes toward the vaccine11,12 to 
negative attitudes13 to being more evenly divided.14 The presence of 
negative HPV vaccine-related internet posts are of particular impor-
tance, as they can lead to negative perceptions about the vaccine and 
can encourage audiences to post negative messages, whereas positive 
messages appear to not encourage positive perceptions and positive 
message sharing.15,16
The influence of social media messages on guardian decision-
making to get their children the HPV vaccine, especially in a specific 
geographical context, is not well-studied. Considering that 88% of 
U.S. adults use the internet and 79% use social media,17 it is estimated 
that 1.9 million Kansas adults are internet users and 1.5 million use 
social media.18 Thus, social media messages about HPV and the HPV 
vaccine likely influence statewide HPV vaccination rates.
The purpose of this study was to evaluate how Kansas guardians 
of children ages 9 - 17 perceive HPV and the HPV vaccine, perceive 
social media messages about HPV and HPV vaccines and, in turn, 
assess how those messages influence their own perceptions about 
getting their children vaccinated against HPV.
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Study Design and Participants. From January 31 - March 21, 
2017, data were collected via an online survey. To recruit partici-
pants, the researcher contacted each of the 105 Kansas county health 
department administrators, along with the directors of the Kansas 
Department of Health and Environment, via an email requesting 
assistance with distribution. Each email was followed up by phone 
call. A total of 38 county health departments (Barber, Barton, Butler, 
Chautauqua, Cherokee, Clark, Clay, Crawford, Douglas, Ellis, Finney, 
Graham, Grant, Harvey, Hodgeman, Jewell, Johnson, Logan, Mar-
shall, Meade, Osage, Ottawa, Pawnee, Pottawatomie, Reno, Rice, Riley, 
Shawnee, Sheridan, Sherman, Stafford, Stanton, Stevens, Thomas, 
Wichita, Wilson, Washington, and Wyandotte), the Bureau of Family 
Health Director, and the Director of the Bureau of Disease Control 
agreed to assist in distributing the survey by posting the hyperlink to 
their department websites and social media pages. The researcher 
also posted the hyperlink on personal Facebook and Twitter pages. 
Participants also were encouraged to pass the link on to other poten-
tial participants. The survey was also available and compatible for 
smartphone and tablet use. A total of 233 people started the survey. 
Responses were voluntary and anonymous. The University of Kansas 
Human Research Protection Program (HRPP; formerly the Human 
Subjects Committee – Lawrence [HSCL]) approved the instruments 
and collection procedures of this study. 
Measures. The survey included items on participant demographic 
characteristics (sex, guardian identity, age, race, ethnicity, highest 
level of education, annual household income, and region of resi-
dence), along with their children’s (aged 9 - 17 years) demographic 
information (sex and age) and HPV vaccination status (did guardian 
ever talk to this child about HPV vaccination, has a healthcare provid-
er mentioned getting this child vaccinated against HPV, did this child 
receive the HPV vaccine, and was there intent to get an unvaccinated 
child vaccinated against HPV). Additional items included HPV and 
HPV vaccine perceptions, source and social media use, and percep-
tions about HPV and HPV vaccine-related social media messages.
HPV and HPV vaccine perception survey items were based on the 
health belief model19,20 and social amplification of risk framework21,22 
concepts. Unless noted, these outcome measures were indicated 
on 6-point Likert scales, ranging from “1 - strongly disagree” to “6 - 
strongly agree”.
Source and social media use items asked participants their main 
source of learning about HPV and the HPV vaccine, which social 
media accounts they use, if any, if they follow health-related pages, 
and if they had seen, searched for, or posted about HPV and HPV 
vaccine-related information on social media.
Perceptions about HPV and HPV vaccine-related social media 
messages were based on health belief model19,20 and social amplifi-
cation of risk framework21,22 concepts. Unless noted, these outcome 
measures were indicated on 6-point Likert scales, ranging from “1 - 
strongly disagree” to “6 - strongly agree”.
Statistical Analysis. Descriptive statistics were used to report par-
ticipant demographic characteristics, demographic characteristics 
of their children aged 9 - 17 years, and the HPV vaccination status 
of those children. Correlation analyses (Pearson’s R [sex, parental 
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identity, race, ethnicity, and region] and Spearman’s Rho [generation, 
education, and income]) were conducted to test for significant rela-
tionships between participant demographic characteristics and their 
child(ren)’s vaccination status. 
Descriptive statistics were employed to report HPV and HPV 
vaccine perception items. Pearson correlation analyses, along with 
reliability statistics (Cronbach’s alpha) were conducted to develop 
scales. Linear regressions were used to compare scales. Correlation 
analyses were conducted to test for relationships between participant 
demographic characteristics and perception items. ANOVA analy-
ses were used to test relationships between participant demographic 
group characteristics and perceptions.
Descriptive statistics were calculated for source and social media 
use items. A one-sample t-test was used to calculate perceptions of 
social media depiction of the HPV vaccine.
Descriptive statistics were calculated for items about perceptions 
of HPV and HPV vaccine social media messages. Pearson correla-
tion analyses, along with reliability statistics (Cronbach’s alpha) 
were conducted to develop scales. Paired-samples t-tests compared 
participants’ personal perceptions of HPV and the HPV vaccine to 
their perceptions of social media messages about HPV and the HPV 
vaccine. Independent samples t-tests (grouped by whether they had 
seen related information) and one-sample t-tests were performed to 
compare participants’ perceptions about HPV and the HPV vaccine 
on social media. 
Statistical analyses were performed using Qualtrics23 and SPSS 
for Windows, Version 25.0.24 For all Likert scale items, “I don’t know” 
responses were treated as missing cases and not calculated in the 
analysis. The number of responses that were calculated are reported.
RESULTS
Participants. Of the 233 people who began the survey, 73 par-
ticipants were ineligible (screener questions ended the survey for 
participants who indicated that they did not: consent, currently reside 
in Kansas, or were not the guardian of at least one child aged 9 - 17 
years). Of the remaining 160 eligible participants, 95 had heard of 
HPV and the HPV vaccine and completed the survey for a partici-
pation to completion rate of 41.6%. Most of the participants were 
female, identified as mothers, belonged to Generation X, were White, 
non-Hispanic/LatinX, with two- or four-year college degrees, and 
an annual household income of under $100,000. Most of the partici-
pants resided in the Kansas City Metro area and Northeast Kansas. 
The demographic characteristics of the participants are shown in 
Table 2.
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Table 2. Demographic characteristics of Kansas guardians of 
children 9 - 17 years. 
Participants (n = 95)
Sex, No. (%)
Female 83 (87.4)
Male 12 (12.6)
Guardian identity, No. (%)
Mother 83 (87.4)
Father 10 (10.5)
Other 2 (2.1)
Age, years (Generation)25
Age group, No. (%) (n = 85)
31 - 36 (Millennials) 14 (14.7)
37 - 52 (Generation X) 67 (78.8)
53 - 60 (Boomers) 4 (4.2)
Race, No. (%)                                                                                            
White 84 (88.4)
Asian 3 (3.2)
American Indian or Alaska Native 2 (2.1)
Black or African American 2 (2.1)
Multiracial 2 (2.1)
Other 1 (1.1)
Ethnicity, No. (%)
Non-Hispanic/LatinX 91 (95.8)
Hispanic or LatinX 4 (4.2)
Highest level of education, No. (%) (n = 94)                              
Less than a college degree 21 (22.1)
Two or four-year college degree 48 (50.5)
Graduate degree 25 (26.3)
Annual household income, No. (%) (n = 87)                                         
Under $100K 59 (62.1)
$100K + 28 (29.5)
Region of residence5   (n = 94)
Northeast 21 (22.1)
North Central 6 (6.3)
Northwest 8 (8.4)
Southeast 9 (9.5)
South Central 18 (18.9)
Southwest 9 (9.5)
Kansas City Metro 23 (24.2)
Participants’ Children. The participants reported having one to 
four children (M = 1.70, SD = 0.70), aged 9 - 17 years. Most of these 
children were female, with a median age of 13 years. Most of the par-
ticipants reported having conversations about the HPV vaccine with 
their children. Most of the participants also reported that a healthcare 
provider had spoken to them about vaccinating most of their children. 
However, most children had not been vaccinated against HPV. The 
median age of vaccinated children was 14 years, and the median age 
of unvaccinated children was 11 years. Among the unvaccinated chil-
dren, parents most often reported that they definitely planned to get 
their children vaccinated before the child turns 18. The demographic 
characteristics and the HPV vaccination status information about the 
participants’ children ages 9 - 17 years are shown in Table 3.
Table 3. Demographic characteristics of Kansas guardians’ chil-
dren, 9 - 17 years. 
Characteristics Children (n = 160)
Sex, No. (%)                                                                                                (n = 158)
Female 102 (63.8)
Male 56 (35.0)
Age, years
Median (variance) 13 ± 2.50
Talk to child about HPV vaccine, No. (%) (n = 155)                              
Yes 96 (60.0)
No 59 (36.9)
Talked to healthcare provider about getting child HPV vaccine, 
No. (%) (n = 157)
Yes 110 (68.8)
No 43 (26.9)
HPV vaccination status, No. (%) (n = 155)                                             
At least one dose 62 (38.8)
No doses 93 (58.1)
Unvaccinated children (n = 93)
Intent to get child HPV vaccine before 18 years, No. (%)
Definitely yes 25 (26.8)
Probably yes 20 (21.5)
Might or might not 16 (17.2)
Probably not 13 (14.0)
Definitely not 19 (20.4)
Tests for significant relationships between guardian demographics 
(generation, race, ethnicity, education, income, and region of resi-
dence) and child vaccination status (receiving at least one dose, no 
dose) show that children of guardians reporting an annual household 
income of $100,000 or more were significantly more likely to have 
received at least one dose of the HPV vaccine, compared to children 
of guardians with annual household incomes of less than $100,000 (p 
= 0.003). All other relationships were found to be statistically insig-
nificant.
KANSAS JOURNAL of  M E D I C I N EHPV and HPV Vaccine Perceptions. Table 4 summarizes the 
participants’ HPV and HPV vaccine perceptions. HPV vaccine effec-
tiveness perception items (n = 3) were correlated significantly and 
comprised the HPV vaccine effectiveness perception scale (α = 0.76). 
Table 5 provides the correlation coefficients of HPV vaccine effec-
tiveness perceptions. Additionally, HPV vaccine harm perception 
items (n = 5) were correlated significantly and comprised the HPV 
vaccine harm perception scale (α = 0.97). Table 6 provides the cor-
relation coefficients for HPV vaccine harm perceptions.
Table 4. Participant HPV and HPV vaccine perceptions.
Variable Mean SD (n)
HPV Susceptibility
My child is at risk to contract HPV. 4.34 1.47 92
HPV Severity
HPV causes genital warts. 5.11 1.14 79
HPV causes cancer. 5.51 .62 91
HPV can kill my child. 4.21 1.50 90
HPV Vaccine Benefits
HPV vaccine effectiveness perceptions scale 
(α = 0.76) 4.72 1.17 71
HPV vaccine can prevent HPV. 4.60 1.38 91
HPV vaccine can prevent genital warts. 4.50 1.58 72
HPV vaccine can prevent cancer. 4.58 1.43 88
I am a good parent if I get my child the HPV 
vaccine. 3.99 1.66 86
HPV Vaccine Barriers and Risks
HPV vaccine harm perception scale (α = 0.97) 2.94 1.82 72
It is risky for my child to receive the HPV vaccine. 2.81 1.69 89
There are more risks for my child getting the HPV 
vaccine than having HPV. 2.36 1.62 85
My child will experience harmful side effects if 
they receive the HPV vaccine. 2.63 1.49 81
My child is more likely to be harmed by the HPV 
vaccine than having HPV. 2.43 1.66 84
The HPV vaccine could kill my child. 2.25 1.45 85
The HPV vaccine will encourage increased sexual 
activity. 1.48 0.76 94
I have been discouraged from getting my child the 
HPV vaccine. 2.37 1.52 92
The HPV vaccine is inconvenient to get for my 
child. 2.41 1.46 87
Cues to Action
I have been encouraged to get my child the HPV 
vaccine. 4.50 1.37 92
Self-Efficacy
I can protect my child from HPV. 4.96 1.18 94
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Table 5. Correlation coefficients of HPV vaccine effectiveness 
perceptions.
Variables HPV vaccine 
can prevent 
HPV.
HPV vaccine 
can prevent 
genital warts.
HPV vaccine 
can prevent 
cancer.
HPV vaccine 
can prevent 
HPV.
Pearson’s 
Correlation
Sig. 
(2-tailed)
n
HPV vaccine 
can prevent 
genital warts.
Pearson’s 
Correlation 0.500**
Sig. 
(2-tailed) < 0.0001
n 71
HPV vaccine 
can prevent 
cancer.
Pearson’s 
Correlation 0.661** 0.556**
Sig. 
(2-tailed) < 0.0001 < 0.0001
n 87 71
**Correlation is significant at the 0.001 level (2-tailed).
Analyses showed that income had a significant positive correlation 
with participants feeling like they are good guardians if they get their 
child the HPV vaccine (p = 0.047) and with being encouraged to get 
their child the HPV vaccine (p = 0.014). All other relationships were 
found to be insignificant. A regression analysis found that the HPV 
vaccine harm perception scale had a significant positive correlation 
with the perception that the HPV vaccine would cause their child to 
become more sexually active (p = 0.011). Also, an analysis found that 
higher scores on the HPV vaccine harm perception scale (β = -0.451) 
significantly predicted lower scores on the HPV vaccine effectiveness 
perception scale, explaining 38.5% of the variance (R = 0.620; F [1, 
57] = 35.63; p < 0.0001). Furthermore, an analysis of variance showed 
that the effect of region on participants’ perception of HPV vaccine 
inconvenience for their children was significant (F [6, 80) = 2.96; p = 
0.012; see Table 7 for means).
Source and Social Media Use. About 5% of participants reported 
that social media was their main source of information about HPV 
and the HPV vaccine; however, healthcare providers were still the 
main source of information in both cases. Figures 1 and 2 provide 
summaries.
Most participants reported using social media, specifically a Face-
book account (Figure 3).
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Table 6. Correlation coefficients of HPV vaccine harm perceptions.
Variables
It is risky for my child to 
receive the HPV vaccine.
There are more risks 
for my child getting 
the HPV vaccine than 
having HPV.
My child will 
experience harmful 
side effects if they 
receive the HPV 
vaccine.
My child is more 
likely to be harmed 
by the HPV vaccine 
than having HPV.
The HPV 
vaccine could 
kill my child.
It is risky for my 
child to receive the 
HPV vaccine.
Pearson’s 
Correlation
Sig. (2-tailed)
n
There are more 
risks for my child 
getting the HPV 
vaccine than 
having HPV.
Pearson’s 
Correlation 0.874**
Sig. (2-tailed) 0.0001
n 85
My child will 
experience harmful 
side effects if they 
receive the HPV 
vaccine.
Pearson’s 
Correlation 0.910** 0.912**
Sig. (2-tailed) 0.0001 0.0001
n 80 78
My child is more 
likely to be harmed 
by the HPV 
vaccine than 
having HPV.
Pearson’s 
Correlation 0.881** 0.845** 0.878**
Sig. (2-tailed) 0.0001 0.0001 0.0001
n 84 81 77
The HPV vaccine 
could kill my child.
Pearson’s 
Correlation 0.783** 0.709** 0.712** 0.848**
Sig. (2-tailed) 0.0001 0.0001 0.0001 0.0001
n 83 80 77 78
** Correlation is significant at the 0.001 level (2-tailed).
Table 7. Participant perception of HPV vaccine inconvenience for children, region.
Region Mean SD n
South Central 3.06 1.55 18
North Central 3.00 1.23 5
Northeast 2.94 1.68 17
Southeast 2.56 1.74 9
Kansas City Metro 2.00 1.15 22
Northwest 1.57 0.79 7
Southwest 1.33 0.50 9
Total 2.41 1.46 87
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Figure 1. Participant main source for HPV information (n = 95).
Figure 2. Participant main source of HPV vaccine information (n = 95).
             
   
Figure 3. Participant social media use (n = 95).
Forty participants (42.1%) indicated that they follow health-relat-
ed pages on social media. Related to social media use and HPV, most 
(n = 57, 60.0%) had seen information about HPV, 20 participants 
(21.1%) searched for information, and 15 (15.8%) posted or shared 
information. Concerning the HPV vaccine and social media, most 
participants had seen information about the vaccine (n = 56, 58.9%), 
15 (15.8%) had searched for information, and 14 (14.7%) had posted 
information to social media. When asked on a 5-point Likert scale 
(recoded - 2 = “always against,” 2 = “always in favor”), participants 
did not perceive that social media was significantly in favor or against 
the HPV vaccine (n = 55, M = 0.00, SD = 1.20, t(54) = 0.00, p = 1.00).
        HPV/HPV VACCINE AND SOCIAL MEDIA   
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Perceptions of HPV and HPV Vaccine Social Media Messag-
es. Of the 95 respondents, 55 (57.9%) indicated seeing information 
about HPV and the HPV vaccine on social media. Table 8 provides 
summaries of these participants’ characteristics. 
Table 8. Demographic characteristics of Kansas guardians 
of children (9 - 17 years), who viewed HPV and HPV vaccine 
information on social media. 
Characteristics Participants (n = 55)
Sex, No. (%) (n = 55)
Female 49 (89.1)
Male 6 (10.9)
Guardian identity, No. (%) (n = 55)
Mother 50 (90.9)
Father 5 (9.1)
Age, years (Generation)25
Age group, No. (%) (n = 49)
31 - 36 (Millennials) 7 (12.7)
37 - 52 (Generation X) 41 (74.5)
53 - 60 (Boomers) 1 (1.8)
Race, No. (%) (n = 54)
White 51 (92.7)
Non-White 3 (5.5)
Ethnicity, No. (%) (n = 55)
Non-Hispanic/LatinX 53 (96.4)
Hispanic or LatinX 2 (3.6)
Highest level of education, No. (%) (n = 55)
Less than a college degree 11 (20.0)
Two or four-year college degree 29 (52.7)
Graduate degree 15 (27.3)
Annual household income, No. (%) (n = 50)
Under $100,000 33 (60.0)
$100,000 or more 17 (30.9)
Region of residence5  (n = 55)
Northeast 9 (16.4)
North Central 5 (9.1)
Northwest 6 (10.9)
Southeast 6 (10.9)
South Central 12 (21.8)
Southwest 5 (9.1)
Kansas City Metro 12 (21.8)
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Table 9 summarizes participant perceptions of social media mes-
sages about HPV and the HPV vaccine. Social media-based HPV 
vaccine effectiveness perception items (n = 3) were correlated sig-
nificantly and comprised the social media-based HPV vaccine 
effectiveness perception scale (α = 0.90). Table 10 provides the cor-
relation coefficients of social media-based HPV vaccine effectiveness 
perceptions. Additionally, social media-based HPV vaccine harm per-
ception items (n = 5) were correlated significantly and comprised the 
social media-based HPV vaccine harm perception scale (α = 0.96). 
Table 11 provides the correlation coefficients for social media-based 
HPV vaccine harm perceptions.
Table 9. Participant perceptions of social media of HPV and 
HPV vaccine messages. 
Variable Mean SD n
HPV Susceptibility
Your child is at risk to contract HPV. 4.41 1.38 54
HPV Severity
HPV causes genital warts. 4.61 1.30 44
HPV causes cancer. 4.86 1.30 51
HPV can kill my child. 4.00 1.77 48
HPV Vaccine Benefits
Social media-based HPV vaccine effectiveness 
perceptions scale (α = 0.90) 4.50 1.16 37
HPV vaccine can prevent HPV. 4.28 1.44 46
HPV vaccine can prevent genital warts. 4.28 1.41 39
HPV vaccine can prevent cancer. 4.28 1.45 46
I am a good parent if I get my child the HPV 
vaccine. 3.51 1.69 47
HPV Vaccine Risks and Barriers
Social media-based HPV vaccine harm perception 
scale (α = 0.96) 3.53 1.56 44
It is risky for your child to receive the HPV vaccine. 3.69 1.71 51
There are more risks for your child getting the HPV 
vaccine than having HPV. 3.43 1.73 51
Your child will experience harmful side effects if 
they receive the HPV vaccine. 3.59 1.71 51
Your child is more likely to be harmed by the HPV 
vaccine than having HPV. 3.65 1.64 48
The HPV vaccine could kill your child. 3.28 1.73 50
The HPV vaccine will not encourage increased 
sexual activity. 4.06 1.77 51
Society discourages you from getting your child the 
HPV vaccine. 3.78 1.72 50
The HPV vaccine is inconvenient. 2.74 1.51 43
Cues to Action
Society encourages you to get your child the HPV 
vaccine. 3.75 1.66 48
Self-Efficacy
I can protect my child from HPV. 4.72 1.25 53
Table 10. Correlation coefficients of social media-based HPV 
vaccine effectiveness perceptions. 
Variables HPV vaccine 
can prevent 
HPV.
HPV vaccine 
can prevent 
genital warts.
HPV vaccine 
can prevent 
cancer.
HPV vaccine 
can prevent 
HPV.
Pearson’s 
Correlation
Sig. 
(2-tailed)
n
HPV vaccine 
can prevent 
genital warts.
Pearson’s 
Correlation 0.783**
Sig. 
(2-tailed) 0.0001
n 47
HPV vaccine 
can prevent 
cancer.
Pearson’s 
Correlation 0.917** 0.663**
Sig. 
(2-tailed) 0.0001 0.0001
n 45 39
**Correlation is significant at the 0.001 level (2-tailed).
When comparing personal perceptions to perceptions of social 
media messages, personal context scores were significantly higher 
for HPV causing warts and cancer, HPV vaccine harm, HPV vaccine 
discouragement, and HPV vaccine encouragement. Personal context 
scores were significantly lower for HPV vaccine encouraging increased 
sexual activity of child (Table 12).
When participants were grouped by whether they reported seeing 
information about HPV on social media, there were no significant dif-
ferences between groups on how they scored on HPV-related items. 
Concerning perceptions about the HPV vaccine, a one-sample t-test 
analyzed if what they read on social media increases or decreases their 
fear about getting their child the HPV vaccine (-1 = decreases, 0 = 
neither increases nor increases, and 1 = increases). Results indicated 
that participants perceived that their fears were neither significantly 
increased or decreased by social media (M = 0.11, SD = 0.50; t(54) = 
1.63, p = 0.109). Participants who had reported seeing information 
on social media about the HPV vaccine (M= 2.50, SD = 1.62) were 
significantly more likely to perceive that the HPV vaccine could kill 
their child than those who had not seen information (M = 1.74, SD = 
0.85; t(79) = 0.019). All other tests found relationships to be statisti-
cally insignificant.
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Table 11. Correlation coefficients of social media-based HPV vaccine harm perceptions. 
Variables
It is risky for my child to 
receive the HPV vaccine.
There are more risks 
for my child getting 
the HPV vaccine than 
having HPV.
My child will 
experience harmful 
side effects if they 
receive the HPV 
vaccine.
My child is more 
likely to be harmed 
by the HPV vaccine 
than having HPV.
The HPV 
vaccine could 
kill my child.
It is risky for my child 
to receive the HPV 
vaccine.
Pearson’s 
Correlation
Sig. (2-tailed)
n
There are more risks 
for my child getting 
the HPV vaccine than 
having HPV.
Pearson’s 
Correlation 0.766**
Sig. (2-tailed) 0.0001
n 60
My child will 
experience harmful 
side effects if they 
receive the HPV 
vaccine.
Pearson’s 
Correlation 0.922** 0.751**
Sig. (2-tailed) 0.0001 0.0001
n 50 50
My child is more likely 
to be harmed by the 
HPV vaccine than 
having HPV.
Pearson’s 
Correlation 0.810** 0.835** 0.907**
Sig. (2-tailed) 0.0001 0.0001 0.0001
n 47 47 47
The HPV vaccine 
could kill my child.
Pearson’s 
Correlation 0.689** 0.655** 0.724** 0.736**
Sig. (2-tailed) 0.0001 0.0001 0.0001 0.0001
n 50 49 49 46
**Correlation is significant at the 0.001 level (2-tailed).
Table 12. Comparing personal and social media perceptions about HPV and HPV vaccine messages. 
Variable Mean SD n t df Significance (2-tailed)
HPV Susceptibility
Child is at risk to contract HPV -0.19 1.94 53 -0.707 52 0.483
HPV Severity
HPV causes genital warts 0.66 1.44 41 2.92 40 0.006*
HPV causes cancer 0.69 1.35 51 3.63 50 0.001**
HPV can kill my child 0.13 2.12 46 0.42 45 0.679
HPV Vaccine Benefits
HPV vaccine effectiveness perceptions scale 0.190 1.23 35 0.92 34 0.37
Good parenting if child receives HPV vaccine 0.39 1.54 46 1.72 46 0.092
HPV Vaccine Risks and Barriers
HPV vaccine harm perception scale 0.95 2.66 38 1.82 37 0.03*
HPV vaccine encouragement of increased sexual activity -1.58 1.81 52 -6.29 52 0.0001**
Discouragement from getting child HPV vaccine -1.06 2.17 48 -3.40 48 0.001**
HPV vaccine inconvenience -0.10 1.44 42 -0.43 41 0.672
Cues to Action
Encouragement to get child HPV vaccine 0.69 2.17 48 2.19 47 0.03*
Self-Efficacy
Ability to protect child from HPV -1.57 1.35 53 1.62 52 0.11
*Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.001 level (2-tailed).
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DISCUSSION
This study suggested that social media may have a negative influ-
ence on Kansas guardian perceptions of the HPV vaccine. While 
guardians who reported seeing information about the HPV vaccine 
on social media perceived a divided climate and were not being influ-
enced by it, they were significantly more likely to believe that the HPV 
vaccine can kill their child. This is aligned with findings that exposure 
to negative social media messages about the HPV vaccine can lead to 
audiences holding negative perceptions.15,16 The idea of parents fearing 
vaccines is also not a completely new concept. A survey of U.S. adults 
found that 32% believe that the risks of childhood vaccine side effects 
are “medium” or “high”.26
Guardians appear to take the threat of HPV, in terms of causing 
cancer and genital warts, seriously. The participants believed their 
perceptions of HPV risks to be stronger than social media depictions. 
However, Kansas guardians also believed that their perceptions of 
the HPV vaccine’s potential to cause harm to their children were also 
stronger than social media depictions. 
Healthcare providers are the dominant primary source for infor-
mation about HPV and the HPV vaccine. While a small percentage 
of guardians reported that social media is their main source of infor-
mation about HPV and the HPV vaccine, most participants reported 
seeing information about these topics on social media. This result 
further suggested that social media is influencing many Kansas 
guardians about the HPV vaccine. Future efforts to increase HPV 
vaccination rates among Kansas children may best be directed at 
addressing social media messaging, guardians’ fears about the HPV 
vaccine killing their children, and HPV vaccine effectiveness, rather 
than the threat that HPV poses. 
The study suggested that, even though vaccination can begin as 
early as age 9, Kansas guardians are waiting until their children are 
teenagers before getting them the HPV vaccine. Regionally, guard-
ians residing in South Central and North Central Kansas, mostly rural 
areas, perceived the vaccine as inconvenient. The CDC reported that 
adolescents in rural areas trail urban adolescents in HPV vaccination 
rates.27 Future research can analyze inconvenience factors that par-
ticularly address rural citizens and perceptions of the HPV vaccine. 
Furthermore, children of guardians with an annual household income 
of under $100,000 are more likely to not receive the HPV vaccine. 
This is contrary to national reports, where adolescents above the 
poverty line trail those who are below it for HPV vaccination rates.28 
For wealthier guardians, being encouraged to get their children vac-
cinated and feeling like they are good parents for doing so, appeared 
to have a role in the higher vaccination rates among their children. 
Future research with larger, representative, and non-convenience 
samples exploring guardian reasons for delayed HPV vaccination, 
lower vaccination rates among lower socioeconomic groups, and com-
paring Kansas with other regions can enhance understanding of and 
improve HPV vaccination uptake among children in Kansas.
CONCLUSION
This study showcased the perceptions that Kansas guardians of 
children ages 9 - 17 have about HPV and the HPV vaccine, their per-
ceptions of how HPV and the HPV vaccine are represented on social 
media, and the potential influence that social media has on their per-
ceptions. Given the ubiquity of social media and the pervasiveness of 
HPV and HPV vaccine messages, its potential effects should not be 
ignored. Continued research and efforts to understand and harness 
the power of social media on the HPV vaccine are needed, specifically 
fear and acceptance, among Kansas guardians. These efforts are nec-
essary to increase vaccination uptake among their children, thereby 
reducing the future HPV-related disease burden.
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